We serve Chemical Name:2-Anilinothieno[3,2-b]pyridine-3-carbonitrile CAS:212916-26-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Anilinothieno[3,2-b]pyridine-3-carbonitrile
CAS.NO:212916-26-2
Synonyms:2-Anilinothieno[3,2-b]pyridine-3-carbonitrile
Molecular Formula:C14H9N3S
Molecular Weight:251.30600
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:76.95000
Exact Mass:251.05200
LogP:3.98458
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Anilinothieno[3,2-b]pyridine-3-carbonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Anilinothieno[3,2-b]pyridine-3-carbonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Anilinothieno[3,2-b]pyridine-3-carbonitrile Use and application,2-Anilinothieno[3,2-b]pyridine-3-carbonitrile technical grade,usp/ep/jp grade.
Related News: By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed. 2-Anilinothieno[3,2-b]pyridine-3-carbonitrile manufacturer By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed. 2-Anilinothieno[3,2-b]pyridine-3-carbonitrile supplier By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed. 2-Anilinothieno[3,2-b]pyridine-3-carbonitrile vendor By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed. 2-Anilinothieno[3,2-b]pyridine-3-carbonitrile factory Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).